Latest Updates

    None Found

Seaside Therapeutics & Roche Announce Alliance to Advance Treatments

Seaside Therapeutics of Cambridge, MA along with Hoffman-La Roche announced their landmark alliance today to advance treatment for fragile X syndrome and autism spectrum disorders. The National Fragile X Foundation shared the press release on their website earlier today and plan to add additional commentary later this afternoon. Be sure to stop in and check out the post for the latest updates!

1 comment to Seaside Therapeutics & Roche Announce Alliance to Advance Treatments

  • Your doctor can confirm the presence of a fragile X premutation or mutation by taking a sample of blood and sending it for a DNA test that will count the number of CGG repetitions in the FMR1 gene.

Leave a Reply

 

 

 

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>